AN ORGANIZATION STUDY

GLAXOSMITHKLINE
Presented by:Mr. Mehsum Ali
Mr. Ali Ather Mohsin
Mr.Mohammad Arif
Mr. Taj-ud-din
Mr. Muhammad Ali Hashmi

TOPICS TO COVER
Introduction and Background
Vision and Mission
Product line
GSK Management
Organizational Chart
Management Levels
SWOT Analysis
Porters Strategies
Questions and Answers

INTRODUCTION AND BACKGROUND

GlaxoSmithKline plc (LSE: GSK NYSE: GSK), often
abbreviated to GSK, is a global pharmaceutical,
biologics, vaccines and consumer healthcare
company headquartered in London, United
Kingdom. It is the world's Fourth largest
pharmaceutical company measured by revenues
(after Johnson & Johnson, Pfizer & Roche.
GSK was formed in 2000 by the merger of
GlaxoWellcome plc (formed from the acquisition of
Wellcome plc by Glaxo plc), and SmithKline
Beecham plc (from the merger of Beecham plc, and
SmithKlineBeckman Corporation).

IN PAKISTAN

GlaxoSmithKline Pakistan Limited came into

existence after the merger of Smith Kline and
French of Pakistan Limited and Beecham Pakistan
(Private) Limited with Glaxo Wellcome Pakistan
Limited in 2002. It is listed on the Karachi and
Lahore stock exchanges. GSK has a large portfolio
of products ranging tablets, toothpaste, inhalers
and complex capsules in over 28,000 different pack
sizes and presentations.

VISION AND MISSION

The

opportunity to make a
difference to the lives of billions of
people.

GlaxoSmithKline

has a challenging
and inspiring mission their mission is
to improve the quality of human life by
enabling people to do more, feel better
and live longer

PRODUCT LINE

GSK MANAGEMENT
The company is managed by the Board of Directors
and the Corporate Executive Team.
The Board is comprised of executive and nonexecutive directors who are responsible for their
corporate governance and ultimately accountable
for their activities, strategy and performance.
The Chief Executive Officer (CEO) is responsible
for the management of the business and is assisted
by the Corporate Executive Team that manages
their activities. Each member is responsible for a
specific part of the business.

ORGANIZATIONAL CHART
Board of Directors

Chairmain & CEO

Deput
chairman
Advisory
Committee on
Administration
Development

Executive
Directors

Trade Net Dept.

Sales
Management
Dept.

Quality
Controle Dept.

Finance
Department

Human
Resource
Dept.

Marketing
Management
Dept.

International
Trade Ins.

National Sales
Dept.

Product Line
Q.C. Dept

Audit Dept.

Selection &
Recruitment
Dept.

Strategic
Management
Dept.

General
Administration
Dept.

Proviosional
Salels Dept.

Product Q.C.
Dept

Planning &
Finance
Dept.

Area Sales
Dept.

Overseas &
Domestic
Branch office

Product
Management
Dept.

MANAGEMENT LEVELS
The

management levels of GSK

are as follows:Executive-Level
Director-Level
Manager-Level
Staff

SWOT ANALYSIS

STRENGTHS

THREATS

WEAKNESSES

OPPURTUNITIES

Strengths:
Strong Management Team
Large Market Share
Highest research Products in Pakistan
Wide range of Products

Opportunities:
Emerging markets and expansion abroad
Have great chance to cash its brand
name in the field of surgical market
GSK can be able to cash its name in
baby foods

Weaknesses:
No online presence in Pakistan
Strong focus on UK market (losing
opportunities in Pakistan)
Less checking on the sales
representatives for their working in field

Threats:
Lower cost competitors or imports like
Chinese and Indian medicines etc
Patent expiry on drugs that generate
strong income
Increasing cost of drug trials (research)
and ever higher standards imposed by
national drug approvals bodies.

PORTERS STRATEGIES

TO GROW A DIVERSIFIED GLOBAL BUSINESS.

DELIVER VALUE PRODUCTS

SIMPLIFYING THE OPERATING MODEL

CHALLENGING AND INSPIRING MISSION

LONG TERM INCENTIVE PLAN

Increase growth in the pharmaceutical business in

its core market.
GSK is diversifying its business to bring balance in
product portfolio & go away from a reliance on
traditional markets.
GSK expects to generate future sales growth by
strengthening its core pharmaceutical business &
supplementing it with increased investment in
growth such as; vaccines, dermatology and
consumer health care.
Business expansion inn Japan
Build a leadership in dermatology.

Focusing on the best science

Focus on research and development

Diversifying the level of externalization in research

to focus on disease area, where GSK believe the
prospects for successful registration and launch of
differentiated medicines.

As GSK continue to change shape, so it is essential

that reduce the complexities in operating model,
improve efficiencies and reduce cost.

Re-shape manufacturing

GSK has a challenging vision and mission is to

improve the quality of human life by making people
to do more, feel better and live longer.

Long term incentive plan.

awards are made to executives under the
following long term incentive plan,
i) Deferred annual bonus plan
ii)
Performance share plan

Explanation: Deferred Annual bonus plan:

The deferred annual bonus plan
encourages long term shareholding, discourages
excessive risk taking and help focus on GSKS
key strategic priorities.

Performance share : the performance share plan

ensure focus on the delivery of GSKS strategic
priorities and long term share holders returns
relative to other pharmaceutical companies.

Meeting with DR. AHMED FARHAN

Questionnaire MANAGER AND STAFF

Interview DR. AHMED FARHAN

GSK annual report 2011.

www.gsk.com

Term report of GSK

Wikipedia,2011